CDKN1A and melanoma: As, in melanoma, CDKN2A (which encodes p16) has often sequence variants that result in loss of p16 function [12,16,33], the cell cycle arrest in senescent melanoma cells may be primarily mediated by p21, which is a downstream target of the tumor suppressor p53 [34].